Skip to main content

Kazia Therapeutics Ltd

KZIA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001075880

No open-market purchases or sales by Kazia Therapeutics Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $50.7M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Kazia Therapeutics Ltd as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
18
+8 vs. Q3 2023
Shares held
4.88M
+4.65M (+1,959.3%) vs. Q3 2023
Total value
$2.15M
+$1.92M (+812.3%) vs. Q3 2023
New holders
10
3 more added
Sold out
2
1 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KZIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 18 institutions
Q1 2021: 14 institutionsQ2 2021: 15 institutionsQ3 2021: 18 institutionsQ4 2021: 12 institutionsQ1 2022: 12 institutionsQ2 2022: 12 institutionsQ3 2022: 9 institutionsQ4 2022: 10 institutionsQ1 2023: 8 institutionsQ2 2023: 9 institutionsQ3 2023: 10 institutionsQ4 2023: 18 institutionsQ1 2024: 11 institutionsQ2 2024: 11 institutionsQ3 2024: 18 institutionsQ4 2024: 11 institutionsQ1 2025: 10 institutionsQ2 2025: 10 institutionsQ3 2025: 11 institutionsQ4 2025: 22 institutionsQ1 2026: 23 institutionsQ2 2026: 35 institutions
Value heldQ4 2023: $2.15M
Q1 2021: $4.60MQ2 2021: $4.35MQ3 2021: $5.03MQ4 2021: $4.01MQ1 2022: $2.90MQ2 2022: $1.24MQ3 2022: $527.0KQ4 2022: $262.0KQ1 2023: $279.4KQ2 2023: $327.6KQ3 2023: $235.9KQ4 2023: $2.15MQ1 2024: $115.5KQ2 2024: $89.5KQ3 2024: $922.0KQ4 2024: $569.1KQ1 2025: $120.9KQ2 2025: $902.9KQ3 2025: $1.14MQ4 2025: $17.1MQ1 2026: $13.0MQ2 2026: $50.7M
Institutions holding KZIA and their total value by quarter
QuarterHoldersValue
Q2 202635$50.7M
Q1 202623$13.0M
Q4 202522$17.1M
Q3 202511$1.14M
Q2 202510$902.9K
Q1 202510$120.9K
Q4 202411$569.1K
Q3 202418$922.0K
Q2 202411$89.5K
Q1 202411$115.5K
Q4 202318$2.15M
Q3 202310$235.9K
Q2 20239$327.6K
Q1 20238$279.4K
Q4 202210$262.0K
Q3 20229$527.0K
Q2 202212$1.24M
Q1 202212$2.90M
Q4 202112$4.01M
Q3 202118$5.03M
Q2 202115$4.35M
Q1 202114$4.60M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Kazia Therapeutics Ltd; share changes are against Q3 2023.

Institutions holding KZIA in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC2,475,555$1.09M0.03%+2,475,555New
Platinum Investment Management Ltd1,821,887$800.7K0.03%+1,821,887New
Morgan Stanley201,550$88.6K0.00%+11,600+6.1%Added
Bank of Montreal140,166$65.9K0.00%+140,166New
HSBC Holdings PLC100,194$45.1K0.00%+100,194New
Two Sigma Securities, LLC58,423$25.7K0.00%+58,423New
XTX Topco Ltd19,436$8.73K0.00%+19,436New
Acadian Asset Management LLC18,682$8.00K0.00%00.0%Unchanged
Citadel Advisors LLC12,809$5.75K0.00%+12,809New
BNP Paribas Arbitrage, SA12,700$5.58K0.00%+4,200+49.4%Added
Virtu Financial LLC11,449$5.00K0.00%−190−1.6%Reduced
Rhumbline Advisers9,710$4.36K0.00%+2,155+28.5%Added
GWM Advisors LLC500$2200.00%00.0%Unchanged
UBS Group AG100$440.00%+100New
Allworth Financial LP87$390.00%00.0%Unchanged
McGlone Suttner Wealth Management, Inc.85$370.00%+85New
AdvisorNet Financial, Inc5$20.00%00.0%Unchanged
Simplex Trading, LLC190$00.00%+190New
Bank of America Corp0$00.00%−200−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−25−100.0%Sold out